World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
32168
World Ranking
7752
National Ranking
4038

Edwin P. Alyea publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Edwin P. Alyea sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 498 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Edwin P. Alyea D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Edwin P. Alyea sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Edwin P. Alyea is affiliated with Harvard University in the United States and specializes primarily in the field of Medicine. Their research encompasses several subfields with a strong focus on Hematology, Genetics, Oncology, Immunology, and Public Health, Environmental and Occupational Health. The scientist's work predominantly centers around topics such as Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, and Acute Lymphoblastic Leukemia research.

Their publication record includes contributions to major academic journals with repeated appearances in Blood Advances, Transplantation and Cellular Therapy, Blood, Biology of Blood and Marrow Transplantation, and UNC Libraries. These venues collectively highlight the scientist's involvement in studies related to hematologic malignancies and transplantation science.

Recent publications authored or co-authored by Edwin P. Alyea include:

  • Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial, 2021, Transplantation and Cellular Therapy
  • Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide, 2021, Blood Advances
  • Survival following allogeneic transplant in patients with myelofibrosis, 2020, Blood Advances
  • A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation, 2020, Blood
  • Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML, 2022, Blood

Edwin P. Alyea's frequent collaborators include Robert J. Soiffer, Vincent T. Ho, Haesook T. Kim, Corey Cutler, and Mitchell E. Horwitz, reflecting interdisciplinary cooperation within hematology and transplantation research. These coauthors have contributed to multiple joint projects, with collaboration counts ranging from 16 to 25 publications.

Best Publications

  • Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

    John Koreth;Ken Ichi Matsuoka;Haesook T. Kim;Sean M. McDonough

  • Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

    Philippe Armand;Haesook T. Kim;Brent R. Logan;Zhiwei Wang

  • Ipilimumab for Patients with Relapse after Allogeneic Transplantation

    Matthew S. Davids;Haesook T. Kim;Pavan Bachireddy;Caitlin Costello

  • Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

    Bart L. Scott;Marcelo C. Pasquini;Brent R. Logan;Juan Wu

  • Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.

    Emmanuel Zorn;Haesook T. Kim;Haesook T. Kim;Stephanie J. Lee;Stephanie J. Lee;Blair H. Floyd;Blair H. Floyd

  • Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

    David B. Miklos;David B. Miklos;Haesook T. Kim;Haesook T. Kim;Katherine H. Miller;Katherine H. Miller;Luxuan Guo;Luxuan Guo

  • Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

    Philippe Armand;Haesook T. Kim;Corey S. Cutler;Vincent T. Ho

  • Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease

    Ken-ichi Matsuoka;John Koreth;Haesook T. Kim;O. Gregory Bascug

  • Rituximab for steroid-refractory chronic graft-versus-host disease.

    Corey Cutler;David Miklos;Haesook T. Kim;Nathaniel Treister

  • Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation

    Rafael Bejar;Kristen E. Stevenson;Bennett Caughey;R. Coleman Lindsley

  • Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma

    Arnold S. Freedman;Donna Neuberg;Peter Mauch;Robert J. Soiffer

  • Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma

    Christopher J Gibson;R Coleman Lindsley;Vatche Tchekmedyian;Brenton G Mar

  • Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

    Martha Wadleigh;Paul G. Richardson;David Zahrieh;Stephanie J. Lee

  • Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant

    Edwin P. Alyea;Robert J. Soiffer;Christine Canning;Donna Neuberg

  • A disease risk index for patients undergoing allogeneic stem cell transplantation

    Philippe Armand;Christopher J. Gibson;Corey Cutler;Vincent T. Ho

  • CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

    Asad Bashey;Asad Bashey;Bridget Medina;Sue Corringham;Mildred Pasek

  • Double unrelated reduced-intensity umbilical cord blood transplantation in adults

    Karen K. Ballen;Thomas R. Spitzer;Beow Y. Yeap;Steven McAfee

  • Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

    Edwin P Alyea;Edwin P Alyea;Haesook T Kim;Haesook T Kim;Vincent T Ho;Vincent T Ho;Corey Cutler;Corey Cutler

  • Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.

    Stefanie Sarantopoulos;Kristen E. Stevenson;Haesook T. Kim;Corey S. Cutler

  • Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease

    Christopher S. Hourigan;Laura W. Dillon;Gege Gui;Brent R. Logan

Frequent Co-Authors

Robert J. Soiffer
Robert J. Soiffer Harvard University
Joseph H. Antin
Joseph H. Antin Dana-Farber Cancer Institute
Vincent T. Ho
Vincent T. Ho Harvard University
Corey Cutler
Corey Cutler Harvard University
Jerome Ritz
Jerome Ritz Harvard University
John Koreth
John Koreth Harvard University
Haesook T. Kim
Haesook T. Kim Harvard University
Philippe Armand
Philippe Armand Harvard University
Catherine J. Wu
Catherine J. Wu Harvard University
Donna Neuberg
Donna Neuberg Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Medical studies in the USA but prefer alternative pathways or need flexible learning options, there are several related online degree programs to consider. Many students explore nursing, as it remains a highly in-demand field. For those seeking a quicker entry into the profession, adn programs (Associate Degree in Nursing) offer a streamlined route to becoming a registered nurse, often taking just two years.

Those looking for non-clinical roles can consider medical billing and coding. With plenty of remote opportunities, you have access to financial aid for medical billing and coding programs, making them more affordable and accessible.

If you already hold a bachelor’s degree and want to transition into nursing, there are absn programs that don't require teas exams, helping you fast-track your medical career without extra testing hurdles.

Administrative roles in healthcare are growing, too. If you aim to quickly move into healthcare leadership, consider a accelerated healthcare administration degree—a practical option that prepares graduates for management positions in a dynamic industry.

Best Scientists Citing Edwin P. Alyea

Trending Scientists

Recently Published Articles